November 2020 Volume 16, Issue 10
Volume 16, Issue 10 | November 2020
November 2020
In this Issue
Business & Government Policy
Returning to the fold
Illumina acquires cancer-focused GRAIL for $8 billionOn the cutting edge
A roundup of instrumentation, software and other tools and technology newsNo more EUAs for COVID-19 tests
FDA makes a change in its policy of reviewing and granting tests related to the pandemicA seed fund to drive biopharma innovation
Pistoia Alliance looks to finance four projects annually from idea to proof of conceptContract Services
Europital expands into a full-service CRO
New capabilities include project management, clinical monitoring and pharmacovigilanceAn acquisition opportunity for CMOs?
Indian dose sites an untapped M&A opportunity for foreign contract manufacturersDiagnostics
A promising biomarker for diagnosing liver disease
Owlstone study pinpoints limonene for early diagnosis of NASH and NAFLDKeeping an eye on neurodegeneration
Potential biomarker for Alzheimer’s, Parkinson’s and other diseases can be found in the eyeBionano Genomics acquires Lineagen
Deal boosts capacity in digital cytogenetics and adds genetic diagnostics for neurodevelopmental disordersClinical Trials
Special delivery
Natural compound attacks Alzheimer’s disease earlyMedable offers fully remote options
Informed consent and re-consent made possible for trials without being physically presentCommentary: Adapting to a decentralized model during COVID-19 and beyond
Even after the coronavirus is tamed, changes being made now to clinical trial design and execution could benefit the clinical research industry moving forwardTargeting beta amyloid oligomers
Four compounds show promise against Alzheimer’sPreclinical
New means for managing myotonic dystrophy
RNA-targeting gene therapy reverses molecular and functional features of DM1 in micePreclinical pancreatic cancer partnership
Relationship targets use of pipeline drug and AI platformBioNTech and Pfizer report BNT162b2 data
BNT162b2 immunization of rhesus macaques results in strong antiviral effects against SARS-CoV-2Hope for frontotemporal dementia patients
Passage Bio plans Phase 1/2 trial of gene therapy in humans based on preclinical resultsResearch & Development
Building a database around RNA and proteins
eCLIP technology helps uncover how RNA binding proteins regulate gene expressionAn antisense-ible arrangement
Evotec and Secarna partner on antisense-based therapeuticsPressure to deliver
Researchers pave a way toward painless transdermal drug deliveryDeveloping a cell therapy control switch
Nutrient-based safety switches can be applied to CAR-T, stem cell and TCR therapiesDiscovery
Game-changer
Druggable pocket in SARS-CoV-2 spike protein could stop virusFinding new drugs with fungi
NIH grant will help researchers learn ways to counter drug resistance via gene editingGetting the lowdown on GLO2
Researchers publish new data on the enzyme glyoxalase II and its role in cellular metabolismArctoris and Syntekabio form research partnership
First step is to assess potential therapeutics for COVID-19A better targeting system
Genetic study of protein levels in diseases could help pinpoint optimal therapeutic targetsFeature
Focus Feature on Cancer Research News: Cellular insights into cancer
Understanding behavior, responses and evolution of cells aids in oncology effortsSpotlight on Cell Biology: Cell biology takes the stage
ASCB|EMBO annual meeting goes virtual this year with cellular research. Two of the most significant changes aside from the online format are that the meeting will feature seven scientific tracks plus an education and professional development track, in addition to member-organized Special Interest Subgroups being held on three days of the meeting.Editor's Focus
Keeping tabs on infectious disease
A look at our new online venue for infectious diseases as well as upcoming coverage
